The global embolotherapy market was valued at US$ 3,545.56 million in 2022 and is projected to grow at a CAGR of 8.4%, reaching US$ 7,942.8 million by the end of 2032. This growth is largely driven by the rising prevalence of cancer and increasing emphasis by key market players on techno